SCHEMBL7343202

SCHEMBL7343202

CCCN(Cc1ccccc1)C1Cc2cccc3oc(=O)n(c23)C1

nearest known ligand 0.82

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 13/20 0.52
DRD2 P14416 6/20 0.52
DRD3 P35462 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6354096 0.90 HTR1A (0.62) HTR1ADRD2DRD3
SCHEMBL7342236 0.78 HTR1A (0.62) HTR1ADRD2DRD3
SCHEMBL6354089 0.77 HTR1A (0.56) HTR1ADRD2DRD3
SCHEMBL7343414 0.74 HTR1A (0.40) HTR1ADRD2DRD3
SCHEMBL7343200 0.70 DRD2 (0.36) HTR1ADRD2DRD3
SCHEMBL6361234 0.70 DRD2 (0.61) HTR1ADRD2DRD3
SCHEMBL7343418 0.69 HTR1A (1.00) HTR1ADRD2DRD3
SCHEMBL7349651 0.68 HTR1A (1.00) HTR1ADRD2DRD3
SCHEMBL7341546 0.68 HTR1A (1.00) HTR1ADRD2DRD3
Hydrochloric Acid SCHEMBL7349931 0.67 HTR1A (1.00) HTR1ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed